Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1946]
News [3593]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Th1/17 hybrid T cells offer potent and durable anti-tumour response in preclinical model
Th1/17 hybrid T cells offer potent and durable anti-tumour response in preclinical model
Bringing natural killer cells to the tumour battlefield
Bringing natural killer cells to the tumour battlefield
Novel approach could limit common complications of immunotherapy
Novel approach could limit common complications of immunotherapy
How chronic inflammation tips the balance of immune cells to promote liver cancer
How chronic inflammation tips the balance of immune cells to promote liver cancer
Mathematical model to predict immunotherapy success
Mathematical model to predict immunotherapy success
For cancer patients with HIV, immunotherapy appears safe
For cancer patients with HIV, immunotherapy appears safe
New research targets cancer's 'Achilles' Heel'
New research targets cancer's 'Achilles' Heel'
Immune cell policing offers insights into cancer, autoimmune disease
Immune cell policing offers insights into cancer, autoimmune disease
Bacteria in the gut modulates response to immunotherapy in melanoma
Bacteria in the gut modulates response to immunotherapy in melanoma
FDA approves axicabtagene ciloleucel for large B-cell lymphoma
FDA approves axicabtagene ciloleucel for large B-cell lymphoma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation